CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan Kaleido Biosciences, Inc. - KLDO CFD

0.38
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.39
Open* 0.4
1-Year Change* 2.56%
Day's Range* 0.38 - 0.45
52 wk Range 0.00-1.94
Average Volume (10 days) 13.60K
Average Volume (3 months) 265.18K
Market Cap 12.79K
P/E Ratio -100.00K
Shares Outstanding 42.62M
Revenue 1.10M
EPS -2.16
Dividend (Yield %) N/A
Beta 0.46
Next Earnings Date Feb 2, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 14, 2022 0.38 0.00 0.00% 0.38 0.38 0.38
Apr 13, 2022 0.39 0.00 0.00% 0.39 0.47 0.38
Apr 8, 2022 0.40 -0.24 -37.50% 0.64 0.64 0.38
Apr 7, 2022 1.46 -0.01 -0.68% 1.47 1.55 1.42
Apr 6, 2022 1.46 -0.02 -1.35% 1.48 1.48 1.42
Apr 5, 2022 1.50 -0.09 -5.66% 1.59 1.62 1.48
Apr 4, 2022 1.59 -0.14 -8.09% 1.73 1.73 1.54
Apr 1, 2022 1.68 0.06 3.70% 1.62 1.70 1.58
Mar 31, 2022 1.60 -0.08 -4.76% 1.68 1.72 1.55
Mar 30, 2022 1.69 -0.14 -7.65% 1.83 1.83 1.69
Mar 29, 2022 1.70 0.02 1.19% 1.68 1.77 1.60
Mar 28, 2022 1.60 -0.13 -7.51% 1.73 1.73 1.50
Mar 25, 2022 1.64 -0.10 -5.75% 1.74 1.74 1.63
Mar 24, 2022 1.74 0.00 0.00% 1.74 1.76 1.68
Mar 23, 2022 1.74 0.01 0.58% 1.73 1.81 1.73
Mar 22, 2022 1.75 0.10 6.06% 1.65 1.75 1.65
Mar 21, 2022 1.63 -0.05 -2.98% 1.68 1.68 1.55
Mar 18, 2022 1.67 0.14 9.15% 1.53 1.71 1.53
Mar 17, 2022 1.56 0.14 9.86% 1.42 1.57 1.42
Mar 16, 2022 1.42 0.04 2.90% 1.38 1.42 1.31

Kaleido Biosciences, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0 0 0 0 0.975 1.104
Total Operating Expense 9.436 27.03 60.683 87.24 79.849 88.771
Selling/General/Admin. Expenses, Total 1.573 6.038 18.621 22.428 23.882 20.968
Research & Development 7.863 20.992 42.062 64.232 55.967 67.803
Operating Income -9.436 -27.03 -60.683 -87.24 -78.874 -87.667
Interest Income (Expense), Net Non-Operating -0.247 -0.512 -0.805 0.968 -2.553 -2.766
Other, Net -0.002 -0.017 -0.256 -0.059 -0.193 0.145
Net Income Before Taxes -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Net Income After Taxes -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Net Income Before Extra. Items -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Net Income -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Income Available to Common Excl. Extra. Items -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Income Available to Common Incl. Extra. Items -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Diluted Net Income -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Diluted Weighted Average Shares 29.3948 29.3948 29.3948 25.7033 33.4502 41.86
Diluted EPS Excluding Extraordinary Items -0.32948 -0.93755 -2.10051 -3.35876 -2.44004 -2.1569
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.32948 -0.93755 -2.10051 -3.33619 -2.44004 -2.1569
Unusual Expense (Income) 0.58 0
Revenue 0.975 1.104
Q4 2020 Q1 2021 Q2 2021 Q3 2021 Q4 2021
Total revenue 0.243 0.297 0.211 0.104 0.492
Revenue 0.243 0.297 0.211 0.104 0.492
Total Operating Expense 19.543 22.645 23.418 22.517 20.191
Selling/General/Admin. Expenses, Total 5.205 5.46 5.785 5.106 4.617
Research & Development 14.338 17.185 17.633 17.411 15.574
Unusual Expense (Income) 0
Operating Income -19.3 -22.348 -23.207 -22.413 -19.699
Interest Income (Expense), Net Non-Operating -0.713 -0.688 -0.681 -0.692 -0.705
Other, Net -0.003 -0.006 -0.001 0.02 0.132
Net Income Before Taxes -20.016 -23.042 -23.889 -23.085 -20.272
Net Income After Taxes -20.016 -23.042 -23.889 -23.085 -20.272
Net Income Before Extra. Items -20.016 -23.042 -23.889 -23.085 -20.272
Net Income -20.016 -23.042 -23.889 -23.085 -20.272
Income Available to Common Excl. Extra. Items -20.016 -23.042 -23.889 -23.085 -20.272
Income Available to Common Incl. Extra. Items -20.016 -23.042 -23.889 -23.085 -20.272
Diluted Net Income -20.016 -23.042 -23.889 -23.085 -20.272
Diluted Weighted Average Shares 35.9841 39.6926 42.5386 42.5776 42.5995
Diluted EPS Excluding Extraordinary Items -0.55625 -0.58051 -0.56158 -0.54219 -0.47587
Diluted Normalized EPS -0.55625 -0.58051 -0.56158 -0.54219 -0.47587
Dividends per Share - Common Stock Primary Issue 0 0 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 4.363 28.551 76.243 73.279 48.721 42.311
Cash and Short Term Investments 2.728 28.456 76.086 71.241 46.222 38.474
Cash & Equivalents 2.728 28.456 76.086 71.241 46.222 38.474
Total Receivables, Net 1.497 0.045 0.005
Prepaid Expenses 0.138 0.05 0.152 2.038 2.499 3.583
Total Assets 4.99 30.747 85.325 82.306 59.344 50.137
Property/Plant/Equipment, Total - Net 0.513 1.975 4.693 6.742 8.462 5.665
Property/Plant/Equipment, Total - Gross 0.628 2.406 5.914 9.281 11.955 11.136
Accumulated Depreciation, Total -0.115 -0.431 -1.221 -2.539 -3.493 -5.471
Other Long Term Assets, Total 0.114 0.221 4.389 2.285 2.161 2.161
Total Current Liabilities 1.21 3.854 11.301 10.377 16.659 29.682
Accounts Payable 0.872 0.864 3.442 2.016 5.389 5.67
Accrued Expenses 0.25 2.615 7.406 7.086 7.356 6.686
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0.104 0.091 0.068 2.634 16.144
Other Current Liabilities, Total 0.088 0.271 0.362 1.207 1.28 1.182
Total Liabilities 6.251 21.932 28.343 33.423 38.848 39.53
Total Long Term Debt 4.951 14.81 14.831 20.391 18.375 5.55
Long Term Debt 4.951 14.81 14.831 20.391 18.375 5.55
Other Liabilities, Total 0.09 3.268 2.211 2.655 3.814 4.298
Total Equity -1.261 8.815 56.982 48.883 20.496 10.607
Preferred Stock - Non Redeemable, Net 15.655 52.494 153.226
Common Stock 0.009 0.005 0.006 0.03 0.036 0.043
Additional Paid-In Capital 0 0.8 9.978 241.412 294.639 375.031
Retained Earnings (Accumulated Deficit) -16.925 -44.484 -106.228 -192.559 -274.179 -364.467
Total Liabilities & Shareholders’ Equity 4.99 30.747 85.325 82.306 59.344 50.137
Total Common Shares Outstanding 29.3948 29.3948 29.3948 30.1278 36.0228 42.596
Redeemable Preferred Stock 0 0
Other Current Assets, Total 0.254
Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021
Total Current Assets 48.721 95.032 74.603 58.304 42.311
Cash and Short Term Investments 46.222 92.362 71.979 55.657 38.474
Cash & Equivalents 46.222 92.362 71.979 55.657 38.474
Prepaid Expenses 2.499 2.67 2.624 2.647 3.583
Total Assets 59.344 105.026 84.29 67.804 50.137
Property/Plant/Equipment, Total - Net 8.462 7.833 7.526 7.339 5.665
Property/Plant/Equipment, Total - Gross 11.955 11.889 12.165 12.482 11.136
Accumulated Depreciation, Total -3.493 -4.056 -4.639 -5.143 -5.471
Other Long Term Assets, Total 2.161 2.161 2.161 2.161 2.161
Total Current Liabilities 16.659 12.873 12.269 19.261 29.682
Accounts Payable 5.389 2.412 2.695 3.559 5.67
Accrued Expenses 7.356 4.403 5.014 8.681 6.686
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2.634 4.759 3.667 6.384 16.144
Other Current Liabilities, Total 1.28 1.299 0.893 0.637 1.182
Total Liabilities 38.848 33.252 34.024 38.604 39.53
Total Long Term Debt 18.375 16.433 17.677 15.132 5.55
Long Term Debt 18.375 16.433 17.677 15.132 5.55
Other Liabilities, Total 3.814 3.946 4.078 4.211 4.298
Total Equity 20.496 71.774 50.266 29.2 10.607
Common Stock 0.036 0.042 0.043 0.043 0.043
Additional Paid-In Capital 294.639 368.953 371.333 373.352 375.031
Retained Earnings (Accumulated Deficit) -274.179 -297.221 -321.11 -344.195 -364.467
Total Liabilities & Shareholders’ Equity 59.344 105.026 84.29 67.804 50.137
Total Common Shares Outstanding 36.0228 42.4832 42.5714 42.5801 42.596
Redeemable Preferred Stock 0 0
Other Current Assets, Total 0.254
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -9.685 -27.559 -61.744 -86.331 -81.62 -90.288
Cash From Operating Activities -9.35 -22.495 -46.316 -75.796 -61.518 -77.094
Cash From Operating Activities 0.099 0.316 0.792 1.318 1.823 2.358
Non-Cash Items 0.18 0.738 8.14 10.433 13.728 11.099
Cash Interest Paid 0.125 0.343 0.943 0.881 1.925 2.133
Changes in Working Capital 0.056 4.01 6.496 -1.216 4.551 -0.263
Cash From Investing Activities -0.195 -1.406 -3.002 -3.586 -4.024 -0.691
Capital Expenditures -0.195 -1.406 -3.002 -3.586 -4.024 -1.129
Cash From Financing Activities 10.934 49.736 98.907 74.642 40.399 70.037
Financing Cash Flow Items 0 0 -1.84 -1.158 -0.079 -0.359
Issuance (Retirement) of Stock, Net 5.993 39.86 100.852 68.391 40.546 70.396
Issuance (Retirement) of Debt, Net 4.941 9.876 -0.105 7.409 -0.068 0
Net Change in Cash 1.389 25.835 49.589 -4.74 -25.143 -7.748
Other Investing Cash Flow Items, Total 0.438
Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021
Net income/Starting Line -81.62 -23.042 -46.931 -70.016 -90.288
Cash From Operating Activities -61.518 -23.974 -44.057 -59.934 -77.094
Cash From Operating Activities 1.823 0.577 1.16 1.754 2.358
Non-Cash Items 13.728 4.603 7.146 9.331 11.099
Cash Interest Paid 1.925 0.526 1.064 1.601 2.133
Changes in Working Capital 4.551 -6.112 -5.432 -1.003 -0.263
Cash From Investing Activities -4.024 -0.03 -0.262 -0.693 -0.691
Capital Expenditures -4.024 -0.03 -0.262 -0.693 -1.129
Cash From Financing Activities 40.399 70.144 70.076 70.062 70.037
Financing Cash Flow Items -0.079 -0.186 -0.31 -0.329 -0.359
Issuance (Retirement) of Stock, Net 40.546 70.33 70.386 70.391 70.396
Issuance (Retirement) of Debt, Net -0.068 0 0 0
Net Change in Cash -25.143 46.14 25.757 9.435 -7.748
Other Investing Cash Flow Items, Total 0.438
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Trustees of Columbia University in the City of New York Investment Advisor 0.3523 150150 0 2021-09-30 LOW
Menichella (Daniel L.) Individual Investor 0.2996 127700 107700 2022-03-31 MED
Duke (William E. Jr.) Individual Investor 0.1598 68115 68115 2022-03-31 LOW
Korn (Jerald) Individual Investor 0.1215 51803 51803 2022-03-31
Melas-Kyriazi (Theo) Individual Investor 0.0782 33333 0 2022-03-31 LOW
Quinn (Anthony G) Individual Investor 0.0741 31603 0 2022-03-31 LOW
Northern Trust Global Investments Investment Advisor 0.0334 14235 14235 2022-12-31 LOW
DWS Investments UK Limited Investment Advisor 0.0244 10387 10387 2022-12-31 MED
Amalgamated Financial Corp. Investment Advisor 0.0077 3266 3266 2022-03-31
Mackenzie Financial Corporation Investment Advisor/Hedge Fund 0.0027 1139 -148 2022-09-30 LOW
Westfield Capital Management Company, L.P. Investment Advisor/Hedge Fund 0.002 854 0 2021-09-30 LOW
Carroll Financial Associates, Inc. Investment Advisor 0.0008 339 0 2021-12-31

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+485000+

Trader

65000+

Klien aktif per bulan

$48000000+

Volume investasi per bulan

$28000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Biotechnology & Medical Research (NEC)

18 Crosby Dr
BEDFORD
MASSACHUSETTS 01730-1402
US

Income Statement

  • Annual
  • Quarterly

People also watch

Natural Gas

2.48 Price
-1.270% 1D Chg, %
Biaya inap posisi Long -0.0885%
Biaya inap posisi short 0.0595%
Waktu biaya inap 22:00 (UTC)
Spread 0.005

US100

12,737.40 Price
+2.070% 1D Chg, %
Biaya inap posisi Long -0.0174%
Biaya inap posisi short 0.0068%
Waktu biaya inap 22:00 (UTC)
Spread 1.8

BTC/USD

23,849.25 Price
+0.560% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 60.00

Oil - Crude

75.95 Price
-1.090% 1D Chg, %
Biaya inap posisi Long -0.0204%
Biaya inap posisi short 0.0049%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda